The thyroid gland, a small butterfly-shaped organ in the neck, plays a crucial role in regulating metabolism, growth, and development through the production of hormones thyroxine (T4) and triiodothyronine (T3).
T4, primarily a prohormone, is converted into the active T3 in peripheral tissues.
The free T3 (fT3) to reverse T3 (rT3) ratio is a valuable metric for assessing thyroid function and metabolic health.
T3 is the biologically active hormone that influences cellular function, while rT3 is an inactive form produced from T4.
A balanced fT3/rT3 ratio indicates proper thyroid hormone conversion, essential for maintaining metabolic homeostasis.
Evaluating the fT3/rT3 ratio helps in diagnosing and managing thyroid-related disorders and understanding the body's metabolic status under different physiological and pathological conditions.
The thyroid gland, a small butterfly-shaped organ located in the front of the neck, produces hormones that regulate metabolism, growth, and development. The primary hormones produced by the thyroid are thyroxine (T4) and triiodothyronine (T3); T3 acts on almost every single cell in the human body.
T3 and T4 hormones are produced by the follicular cells of the thyroid gland; their production in the thyroid gland is regulated by thyroid-stimulating hormone (TSH) from the anterior pituitary gland.
Metabolic Regulation
Thyroid hormones are essential for controlling the body's metabolic rate, which is the process by which the body converts food into energy. This regulation affects how fast or slow the body's systems function, influencing weight, energy levels, and overall metabolic health.
Growth and Development
In infants and children, thyroid hormones are crucial for brain development and physical growth. They ensure proper development of the nervous system and skeletal system, facilitating normal cognitive and physical maturation.
Cardiovascular System
Thyroid hormones increase cardiac output, heart rate, and stroke volume by enhancing myocardial contractility and reducing peripheral vascular resistance. This ensures efficient blood circulation and oxygen delivery to tissues.
Thermogenesis and Heat Production
By stimulating mitochondrial activity and increasing basal metabolic rate (BMR), thyroid hormones elevate heat production and oxygen consumption. This thermogenic effect is vital for maintaining body temperature and energy balance.
Reproductive Health
Thyroid hormones influence reproductive function by regulating the menstrual cycle in women and spermatogenesis in men. They also modulate the function of other endocrine organs, including the pituitary gland, which in turn affects the release of various hormones that influence reproductive health.
Nervous System
T3 and T4 enhance the function of the central and peripheral nervous systems, increasing alertness, reflexes, and overall responsiveness to stimuli. They also play a role in maintaining mood and cognitive function.
Thyroid hormones exert their influence at the cellular level. Cellular Functions of thyroid hormone include:
Energy Production
At the cellular level, thyroid hormones stimulate the production of ATP, the energy currency of the cell, by increasing the activity of enzymes involved in oxidative phosphorylation. This ensures that cells have sufficient energy to perform their functions efficiently.
Protein Synthesis
Thyroid hormones promote protein synthesis, which is essential for cell growth, repair, and maintenance. This anabolic effect supports the overall health and functionality of tissues and organs.
Gene Expression
T3, the more active form of thyroid hormone, binds to nuclear receptors in cells, influencing the transcription of genes involved in metabolic processes, growth, and differentiation. This regulation of gene expression is fundamental to cellular adaptation and function.
Calcium Homeostasis [3.]
The thyroid gland also produces calcitonin, a hormone that helps regulate calcium levels in the blood by inhibiting bone resorption. This function is crucial for maintaining bone health and preventing hypercalcemia.
Thyroglobulin, a precursor to T4 and T3, is produced by thyroid follicular cells and stored in the follicular lumen.
Meanwhile, iodine uptake occurs to provide iodine, a necessary component of thyroid hormone: iodide is actively absorbed from the bloodstream into the thyroid cells through a process called iodide trapping.
Then, in a process called iodination, iodine is bound to tyrosine residues in thyroglobulin by the enzyme thyroperoxidase, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). Two DIT molecules combine to form T4, while one MIT and one DIT combine to form T3.
When thyroid hormone is released into the bloodstream, proteases digest iodinated thyroglobulin, releasing T4 and T3 into the bloodstream.
T4 is the primary hormone released, constituting about 90% of thyroid hormone output, while T3 makes up about 10%.
T4 is considered a pro-hormone and is converted to the more active T3 in peripheral tissues by deiodinase enzymes. This conversion primarily occurs in the liver, kidneys, and other tissues with high blood flow.
T3 is the active form of thyroid hormone that exerts its effects by binding to nuclear receptors and regulating gene transcription inside cells in various tissues including the liver, heart, skeletal muscle, and brain.
T3 is the thyroid hormone responsible for maintaining basal metabolic rate; regulating protein, lipid, and carbohydrate metabolism; and influencing cardiovascular function and neurological development.
Abnormal levels of T3 can have significant effects on the body.
In the case of too much T3, a condition known as hyperthyroidism, individuals may experience an increased metabolic rate leading to weight loss despite an increased appetite.
Other symptoms include a rapid or irregular heartbeat, nervousness, anxiety, irritability, tremors, muscle weakness, heat intolerance, and excessive sweating. Frequent bowel movements are also common.
During pregnancy, hyperthyroidism can lead to complications such as miscarriage, preterm birth, or fetal growth restriction.
Conversely, too little T3, known as hypothyroidism, results in a slowed metabolism, leading to weight gain. Affected individuals often feel fatigued and weak, and they may experience cold intolerance, depression, cognitive impairment, dry skin, hair loss, and constipation.
In pregnancy, hypothyroidism can result in impaired fetal brain development, low birth weight, and an increased risk of stillbirth.
In both hyperthyroidism and hypothyroidism, severe imbalances can be life-threatening.
A thyroid storm, which is a severe form of hyperthyroidism, can lead to heart failure. In contrast, myxedema coma, a severe form of hypothyroidism, can result in decreased mental status, hypothermia, and multiple organ failure.
Free T3, or free triiodothyronine, refers to the fraction of the thyroid hormone T3 that is not bound to proteins in the bloodstream and is thus available to enter and affect body tissues.
Free T3 is the biologically active form of T3 hormone.
Unlike total T3, which includes both bound and unbound hormone, free T3 specifically measures the active form of T3 that can interact with cells and stimulate various physiological processes.
Reverse T3 (rT3) is typically produced from thyroxine (T4) and is an inactive metabolite. [8.] It is produced from T4 by Deiodinase 3 (DIO3), an enzyme whose role is to protect tissues from excess thyroid hormone exposure. [20.]
While rT3 itself has minimal biological activity, its production competes with the conversion of T4 to the active T3 form. Elevated rT3 levels can indicate a state of reduced T3 production, often seen in conditions such as illness, starvation,metabolic dysfunction or severe stress. [4.]
It can also be upregulated with the use of certain medications such as amiodarone. [8.]
Non-Thyroidal Illness Syndrome (NTIS), also known as Euthyroid Sick Syndrome, refers to a condition observed in seriously ill or starving patients characterized by specific thyroid hormone alterations. In NTIS, the activity of the DIO3 enzyme is upregulated. [21.]
The key features of NTIS include:
NTIS is prevalent among patients in intensive care units (ICUs) and is associated with poor prognosis when total T4 levels are below 4 μg/dL.
The syndrome results from a combination of factors including suppressed thyrotropin-releasing hormone (TRH) release, reduced T3 and T4 turnover, decreased liver generation of T3, increased formation of rT3, and tissue-specific downregulation of deiodinases, transporters, and thyroid hormone (TH) receptors.
Although NTIS has been recognized for nearly four decades, its interpretation remains debated, particularly regarding the appropriateness of thyroid hormone replacement therapy. [4.]
The fT3/rT3 ratio provides insights into the balance between active and inactive thyroid hormones.
The fT3/rT3 ratio is helpful in its ability to assess peripheral thyroid hormone conversion. [12.] As reverse T3 levels rise as in illness, stress, or decreased metabolic capacity, free T3 levels decline. Therefore, the fT3/rT3 ratio will also decline.
When the fT3/rT3 ratio indicates normal peripheral conversion of thyroid hormones, this suggests that elevated TSH levels are not due to impaired peripheral thyroid hormone metabolism but could be attributed to other factors such as hypothyroidism or hormone resistance.
Thyroid hormone resistance (THR) is a rare genetic condition characterized by reduced sensitivity of target tissues to thyroid hormones.
This results in impaired thyroid hormone action despite normal or elevated levels of thyroid hormones in the blood.
Thyroid hormone resistance is a syndrome where the body's tissues have a decreased responsiveness to thyroid hormones, typically due to mutations in the thyroid hormone receptor genes.
This condition is characterized by elevated levels of free thyroid hormones (T3 and T4) in the presence of normal or elevated levels of thyroid-stimulating hormone (TSH).
Patients with THR may exhibit symptoms of both hypothyroidism and hyperthyroidism, depending on the specific tissues affected and the degree of resistance.
In true hypothyroidism, there is an inherent deficiency in thyroid hormone production by the thyroid gland, leading to low levels of T3 and T4. This condition is typically accompanied by elevated TSH levels as the body attempts to stimulate the thyroid gland to produce more hormones.
However, in hypothyroidism, peripheral conversion of T4 to T3 and reverse T3 may be normal. [12.]
On the other hand, decreased peripheral conversion refers to the body's reduced ability to convert T4 into the active hormone T3, often resulting in increased levels of reverse T3 (rT3).
Decreased peripheral conversion can be seen in various non-thyroidal illnesses and conditions such as starvation, stress, or metabolic disturbance, where the thyroid gland may still produce sufficient T4, but its conversion to T3 is impaired.
In these scenarios, the fT3/rT3 ratio is used to assess how well peripheral hormone conversion is operating. [12.]
A declining fT3/rT3 ratio means that reverse T3 levels are climbing respective to fT3 levels. In these situations, individuals should be assessed for common causes of increased rT3 production:
Measuring the fT3/rT3 ratio involves laboratory testing of free triiodothyronine (fT3) and reverse triiodothyronine (rT3) levels in the blood.
Measuring the fT3 and rT3 levels is a blood test which requires a venipuncture.
Avoiding biotin supplements for at least 72 hours prior to testing is recommended. It is also important to know that high estrogen from birth control, estrogen replacement therapy, or pregnancy can cause increased T3 and T4 levels by increasing the amount of binding protein. [1.]
The fT3/rT3 ratio is calculated by dividing the fT3 concentration by the rT3 concentration.
Optimal levels of the fT3/rT3 ratio should be determined for an individual based on the context of their medical history, current concerns, and symptoms, as well as their subjective experience.
One research paper reports the following optimal levels for reducing the risk of chronic disease: [11.]
FT3 (Free T3): levels in the upper 20% of the normal range.
TT3/RT3 Ratio (Total T3/Reverse T3): optimal ratio is between 10 and 15.
While this doctor uses total T3 levels against rT3 levels, he states that a high TT3/rT3 ratio indicates effective metabolism, while a low ratio may indicate a slowed metabolism and suboptimal cellular function. This can be extrapolated to the fT3/rT3 ratio.
One lab provides the following values for fT3, rT3, and their ratio (note the differences in units): [17.]
Free T3/Reverse T3 Ratio: 1.53-2.80
Free T3: 230-420 pg/dL
Reverse T3: 70-260 pg/mL
In the absence of symptoms of hyperthyroidism, an elevated fT3/rT3 ratio is not considered significant.
If symptoms are present, further assessment for hyperthyroidism is warranted.
A decreased fT3/rT3 ratio indicates increased conversion of rT3 relative to T3. Conditions associated with this include NTIS/Euthyroid Sick Syndrome, starvation, liver disease, inflammatory conditions including diabetes, decreased cardiac function, and certain medications.
The interpretation of the fT3/rT3 ratio is often complemented by other thyroid-related biomarkers, providing a comprehensive assessment of thyroid function and metabolic status.
TSH is a pituitary hormone that regulates the production of thyroid hormones T4 and T3 by the thyroid gland.
Measuring TSH levels is a sensitive indicator of thyroid function, as TSH levels increase in primary hypothyroidism and decrease in hyperthyroidism.
TSH testing is often used in conjunction with the fT3/rT3 ratio to differentiate between various thyroid disorders.
T4 is the predominant thyroid hormone released into circulation by the thyroid gland, at which time most of it is bound by a carrier protein. Bound T4 acts as a hormone reservoir, and is not biologically active until it is released from its carrier protein.
Free T4 (fT4) is the unbound and biologically active form of thyroxine.
Measuring total and free T4 levels helps assess the overall thyroid hormone production and can provide insights into the etiology of thyroid disorders, particularly when combined with TSH and fT3/rT3 ratio.
Thyroid autoantibodies such as anti-thyroid peroxidase (TPO) and anti-thyroglobulin (TgAb) antibodies are markers of autoimmune thyroid disorders like Hashimoto's thyroiditis.
Testing for these antibodies can aid in the differential diagnosis of thyroid disorders and may be useful in interpreting the fT3/rT3 ratio in certain clinical scenarios.
fT3 (Free Triiodothyronine) is the active form of the thyroid hormone that circulates unbound in the bloodstream. It is important in regulating metabolism, stimulating energy production, and affects various physiological processes.
rT3 (Reverse Triiodothyronine) is an inactive form of the thyroid hormone. It is produced when the body converts thyroxine (T4) into an inactive form rather than into active T3.
High levels of rT3 can indicate an imbalance in peripheral thyroid hormone conversion.
The fT3/rT3 ratio is a calculated value that compares the levels of active thyroid hormone (fT3) to inactive thyroid hormone (rT3) in the blood. It is used to assess thyroid function and the body's ability to convert T4 into the active T3 hormone.
The fT3/rT3 ratio is measured through blood tests that separately quantify the levels of free T3 and reverse T3. The ratio is then calculated by dividing the fT3 level by the rT3 level.
A normal fT3/rT3 ratio typically falls between 10 and 20. However, the optimal range can vary based on individual health factors and the specific reference ranges used by the testing laboratory.
It's important to consult with a healthcare provider for accurate interpretation.
Elevated levels of the fT3/rT3 ratio can indicate:
Low levels of the fT3/rT3 ratio can indicate:
Management of abnormal fT3/rT3 ratios depends on the underlying cause:
Yes, lifestyle changes can influence thyroid function and the fT3/rT3 ratio:
For more information about the fT3/rT3 ratio and thyroid health, consider consulting:
Click here to compare testing options and order comprehensive thyroid testing.
[1.] American Thyroid Association . Thyroid Function Tests | American Thyroid Association. American Thyroid Association. Published 2019. https://www.thyroid.org/thyroid-function-tests/
[2.] Armstrong M, Asuka E, Fingeret A. Physiology, Thyroid Function. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537039/
[3.] Bancos I. Thyroid and Parathyroid Hormones. www.endocrine.org. Published January 24, 2022. https://www.endocrine.org/patient-engagement/endocrine-library/hormones-and-endocrine-function/thyroid-and-parathyroid-hormones
[4.] DeGroot LJ. The Non-Thyroidal Illness Syndrome. [Updated 2015 Feb 1]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285570/
[5.] Díez JJ, Iglesias P. An analysis of the relative risk for hypothyroidism in patients with Type 2 diabetes. Diabetic Medicine. 2012;29(12):1510-1514. doi:https://doi.org/10.1111/j.1464-5491.2012.03687.x
[6.] Dubczak I, Niemczyk L, Szamotulska K, Jasik M, Rymarz A, Bartoszewicz Z, Niemczyk S. The influence of hypothyroidism and substitution treatment on thyroid hormone conversion ratios and rT3 concentration in patients with end-stage renal failure. Endokrynol Pol. 2019;70(2):165-171. doi: 10.5603/EP.a2018.0087. Epub 2018 Nov 27. PMID: 30480752.
[7.] Ganesan K, Anastasopoulou C, Wadud K. Euthyroid Sick Syndrome. [Updated 2022 Dec 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482219/
[8.] Halsall DJ, Oddy S. Clinical and laboratory aspects of 3,3',5'-triiodothyronine (reverse T3). Ann Clin Biochem. 2021 Jan;58(1):29-37. doi: 10.1177/0004563220969150. Epub 2020 Nov 4. PMID: 33040575.
[9.] Harrison SA, Bashir M, Moussa SE, McCarty K, Pablo Frias J, Taub R, Alkhouri N. Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH. Hepatol Commun. 2021 Jan 4;5(4):573-588. doi: 10.1002/hep4.1657. PMID: 33860116; PMCID: PMC8034581.
[10.] Hatziagelaki E, Paschou SA, Schön M, Psaltopoulou T, Roden M. NAFLD and thyroid function: pathophysiological and therapeutic considerations. Trends Endocrinol Metab. 2022 Nov;33(11):755-768. doi: 10.1016/j.tem.2022.08.001. Epub 2022 Sep 26. PMID: 36171155.
[11.] Levine DT. The definition of Optimal Metabolism and its association with large reductions in chronic diseases. Trends in Medicine. 2018;18(1). doi:https://doi.org/10.15761/tim.1000122
[12.] Lobotková D, Staníková D, Staník J, Cervenová O, Bzdúch V, Tichá L. Lack of association between peripheral activity of thyroid hormones and elevated TSH levels in childhood obesity. J Clin Res Pediatr Endocrinol. 2014;6(2):100-4. doi: 10.4274/Jcrpe.1251. PMID: 24932603; PMCID: PMC4141570.
[13.] Mancini A, Di Segni C, Raimondo S, Olivieri G, Silvestrini A, Meucci E, Currò D. Thyroid Hormones, Oxidative Stress, and Inflammation. Mediators Inflamm. 2016;2016:6757154. doi: 10.1155/2016/6757154. Epub 2016 Mar 8. PMID: 27051079; PMCID: PMC4802023.
[14.] Moura Neto A, Zantut-Wittmann DE. Abnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical Settings. Int J Endocrinol. 2016;2016:2157583. doi: 10.1155/2016/2157583. Epub 2016 Oct 10. PMID: 27803712; PMCID: PMC5075641.
[15.] Patel J, Landers K, Li H, Mortimer RH, Richard K. Thyroid hormones and fetal neurological development. Journal of Endocrinology. 2011;209(1):1-8. doi:https://doi.org/10.1530/JOE-10-0444
[16.] Pimentel CR, Miano FA, Perone D, Conde SJ, Luvizotto Rde A, Padovani CR, Cicogna AC, Filho FR, Nogueira CR. Reverse T3 as a parameter of myocardial function impairment in heart failure. Int J Cardiol. 2010 Nov 5;145(1):52-3. doi: 10.1016/j.ijcard.2009.04.001. Epub 2009 May 9. PMID: 19428128.
[17.] Quest Diagnostics: Test Directory. testdirectory.questdiagnostics.com. Accessed June 26, 2024. https://testdirectory.questdiagnostics.com/test/test-detail/58675/free-t3reverse-t3-ratio?cc=MASTER
[18.] Rivas AM, Lado-Abeal J. Thyroid hormone resistance and its management. Proc (Bayl Univ Med Cent). 2016 Apr;29(2):209-11. doi: 10.1080/08998280.2016.11929421. PMID: 27034574; PMCID: PMC4790576.
[19.] Schlienger JL, Anceau A, Chabrier G, North ML, Stephan F. Effect of diabetic control on the level of circulating thyroid hormones. Diabetologia. 1982 Jun;22(6):486-8. doi: 10.1007/BF00282596. PMID: 6809514.
[20.] Shahid MA, Ashraf MA, Sharma S. Physiology, Thyroid Hormone. [Updated 2023 Jun 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500006/
[21.] Sinha R, Yen PM. Cellular Action of Thyroid Hormone. [Updated 2018 Jun 20]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK285568/
[22.] Triiodothyronine (T3) Tests: MedlinePlus Medical Test. medlineplus.gov. Accessed June 26, 2024. https://medlineplus.gov/lab-tests/triiodothyronine-t3-tests